Twist Bioscience (TWST) Accumulated Depreciation (2020 - 2021)

Twist Bioscience (TWST) reported Accumulated Depreciation of $35.4 million for Q3 2021, up 20.16% year-over-year from $29.5 million in Q3 2020, and up 20.16% quarter-over-quarter from $29.5 million in Q3 2020.

Twist Bioscience (TWST) Accumulated Depreciation (2020 - 2021) Analysis & Trends

Twist Bioscience (TWST) has 2 years of Accumulated Depreciation data on file, last reported at $35.4 million in Q3 2021.

  • Accumulated Depreciation for Q3 2021 came in at $35.4 million, up 20.16% year-over-year; the trailing twelve-month figure through Sep 2021 was $35.4 million (up 20.16% YoY), and the FY2021 annual result was $35.4 million, up 20.16% from the prior year.
  • Accumulated Depreciation grew to $35.4 million in Q3 2021 per TWST's latest filing, from $29.5 million in the prior quarter.
  • Over five years, Accumulated Depreciation peaked at $35.4 million in Q3 2021 and troughed at $29.5 million in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,529.42 Bn 30,528.96 Bn 1.11 Bn
2 Thermo Fisher Scientific 183.75 Bn 180.50 Bn 7.74 Bn
3 Danaher 133.13 Bn 127.43 Bn 3.59 Bn
4 Idexx Laboratories 46.14 Bn 45.94 Bn 722.74 Mn
5 Agilent Technologies 38.20 Bn 36.39 Bn 990.00 Mn
6 Natera 31.50 Bn 30.40 Bn 696.04 Mn
7 Iqvia Holdings 31.34 Bn 29.36 Bn 1.36 Bn
8 Illumina 24.51 Bn 23.36 Bn 721.00 Mn
9 Mettler Toledo International 23.53 Bn 23.47 Bn 555.82 Mn
10 Twist Bioscience 4.30 Bn 4.30 Bn 57.12 Mn

Historic Data

Download Data
DateValue
Sep 30, 2021 35.42 Mn
Sep 30, 2020 29.48 Mn